ITeos Therapeutics Inc (ITOS)
10.81
+0.21
(+1.98%)
USD |
NASDAQ |
Apr 26, 16:00
10.81
0.00 (0.00%)
After-Hours: 18:53
ITeos Therapeutics Market Cap: 387.46M for April 26, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 379.94M |
| April 24, 2024 | 378.86M |
| April 23, 2024 | 393.92M |
| April 22, 2024 | 386.75M |
| April 19, 2024 | 378.50M |
| April 18, 2024 | 370.26M |
| April 17, 2024 | 382.80M |
| April 16, 2024 | 397.86M |
| April 15, 2024 | 421.51M |
| April 12, 2024 | 420.08M |
| April 11, 2024 | 440.87M |
| April 10, 2024 | 438.72M |
| April 09, 2024 | 453.42M |
| April 08, 2024 | 438.00M |
| April 05, 2024 | 443.02M |
| April 04, 2024 | 445.89M |
| April 03, 2024 | 470.26M |
| April 02, 2024 | 454.49M |
| April 01, 2024 | 478.15M |
| March 28, 2024 | 488.90M |
| March 27, 2024 | 472.05M |
| March 26, 2024 | 442.66M |
| March 25, 2024 | 406.82M |
| March 22, 2024 | 401.08M |
| March 21, 2024 | 408.61M |
| Date | Value |
|---|---|
| March 20, 2024 | 396.78M |
| March 19, 2024 | 387.11M |
| March 18, 2024 | 367.75M |
| March 15, 2024 | 387.46M |
| March 14, 2024 | 384.60M |
| March 13, 2024 | 407.54M |
| March 12, 2024 | 413.99M |
| March 11, 2024 | 427.61M |
| March 08, 2024 | 444.10M |
| March 07, 2024 | 415.06M |
| March 06, 2024 | 425.82M |
| March 05, 2024 | 394.99M |
| March 04, 2024 | 397.86M |
| March 01, 2024 | 403.95M |
| February 29, 2024 | 383.83M |
| February 28, 2024 | 386.33M |
| February 27, 2024 | 393.14M |
| February 26, 2024 | 386.69M |
| February 23, 2024 | 381.50M |
| February 22, 2024 | 355.16M |
| February 21, 2024 | 378.09M |
| February 20, 2024 | 368.42M |
| February 16, 2024 | 354.44M |
| February 15, 2024 | 360.89M |
| February 14, 2024 | 362.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
306.86M
Minimum
Oct 12 2023
1.688B
Maximum
Dec 28 2021
793.42M
Average
776.19M
Median
Market Cap Benchmarks
| Gilead Sciences Inc | 81.49B |
| Merck & Co Inc | 332.26B |
| Arcus Biosciences Inc | 1.413B |
| IGM Biosciences Inc | 553.18M |
| Forian Inc | 84.99M |
Market Cap Related Metrics
| PS Ratio | 3.027 |
| Price to Book Value | 0.6736 |
| Price | 10.81 |
| Earnings Yield | -29.14% |
| Normalized PE Ratio | 37.28 |